General Information
As of 05/25/2012
|
| NAV |
$27.05 |
| NAV Daily Change |
($0.02) |
| % Yield |
.04 |
| % SEC Yield |
N/A |
| % YTD Return (as of 04/30/2012) |
14.00 |
| Objective* |
Equity - Sector Health |
| Peer* |
HL MG |
* Key
Portfolio Statistics
|
| % Unrealized Gain YTD |
12.16 |
| Net Assets (Mil $) N/A |
1,359.50 |
| % Turnover N/A |
92.00 |
Fees
|
| % Max Sales Load |
.00 |
| % Min Sales Load |
.00 |
| % Max Deferred Load |
.00 |
Expenses
|
| % Max 12b-1 Fee |
.00 |
| % Max Management Fee |
.56 |
| % Redemption Fee |
.75 |
| % Expense Ratio |
.84 |
Allocation
|
| Large Growth |
21.60 |
| Large Value |
.00 |
| Small Growth |
.00 |
| Small Value |
15.84 |
| Foreign Stock |
.00 |
| Emerging Market |
.00 |
| Precious Metals |
.00 |
| Intermediate Bond |
11.68 |
| Foreign Bond |
.00 |
| High Yield Bond |
33.29 |
Portfolio Information |
| Composition |
| As of N/A |
% of Net Assets |
| Stock |
97.44 |
| Cash |
3.45 |
| Bonds |
.00 |
| Preferred |
.00 |
| Convertibles |
.15 |
| Foreign Stock |
19.16 |
| Foreign Bonds |
.00 |
| Hedge |
.00 |
| Other |
-1.04 |
Sector / Country Weightings
|
| As of 02/29/2012 |
% of Portfolio |
| Health |
63.11 |
| Finance |
12.91 |
| Services |
7.90 |
| Retail Trade |
6.33 |
| Other |
5.52 |
| Technology |
3.21 |
| Industrial Cyclical |
.72 |
| Non-Durable |
.30 |
| N/A |
N/A |
Portfolio Holdings |
Top Equity Holdings
(As of 02/29/2012) |
% of Portfolio |
Value (Mil$) |
|
| COVIDIEN PLC |
14.20 |
193.32 |
| BAXTER INTERNATIONAL INC |
8.54 |
116.26 |
| BOSTON SCIENTIFIC CORP |
6.63 |
90.19 |
| STRYKER CORP |
6.11 |
83.14 |
| COOPER CO INC |
3.85 |
52.46 |
| CR BARD INC |
3.65 |
49.62 |
| DENTSPLY INTERNATIONAL INC |
3.64 |
49.51 |
| UNITEDHEALTH GROUP INC |
3.07 |
41.81 |
| ZIMMER HOLDINGS INC |
2.68 |
36.45 |
| N/A |
N/A |
N/A |
|
|
This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Funds over the next 6 months.
| Zacks Rank |
Definition |
| #1 |
Strong Buy |
| #2 |
Buy |
| #3 |
Hold |
| #4 |
Sell |
| #5 |
Strong Sell |
| S&P |
500 |
Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
Zacks Premium Research
|
Zacks Mutual Fund Rank
|
| |
Find similar funds that have a Mutual Fund Rank.
Find Similar Funds Now  |
Fund Description
|
Incepted in April 1998 and managed by the Fidelity Group, the objective of this health fund is to seek capital appreciation. Normally the fund invests at least 80% of assets in common stocks of companies principally engaged in research, development, manufacture, distribution, supply, or sale of medical equipment and devices and related technologies. The fund offers dividends and capital gains twice a year in April and December.
|
Zacks Commentary for FSMEX
|
|
|
|
Stock Holding Statistics
% of Net Assets
|
| As Of |
N/A |
| Total Issues |
58 |
| Avg. P/E |
33 |
| Avg. P/Book |
6.53 |
| Avg. EPS Growth |
12.04 |
| Avg. Market Value (Mil $) |
13,349 |
Risk
|
|
3 Year |
5 Year |
10 Year |
| Beta |
0.78 |
0.74 |
0.67 |
| Alpha |
1.88 |
5.75 |
5.45 |
| R Squared |
0.61 |
0.61 |
0.54 |
| Std. Dev. |
15.57 |
18.20 |
14.65 |
| Sharpe |
1.15 |
0.34 |
2.00 |
Shareholder Information
|
| Manager |
Edward Yoon |
| Since |
05/07 |
| Manager Rating * SEE EXPLANTION |
3.6 |
| Inception Date |
04/28/1998 |
| Shareholders |
36,520 |
| Dividends Paid |
I |
| Minimum Initial Investment |
$2,500 |
| Minimum Subsequent Investment |
$0 |
| IRA Minimum |
$200 |
| IRA Available |
Y |
Check Writing |
N |
Phone Invest |
Y |
| Phone Exchange |
Y |
Phone Redeem |
Y |
Auto Invest |
Y |
| Wire Redeem |
Y |
Wire Fee |
Y |
Wire Transfer |
Y |
Contact Information
|
| Family |
Fidelity |
| Address |
82 Devonshire St
Boston, MA 02109 |
| Phone |
800 544-6666 |
|
Sponsored Links 
